Cargando…
Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population
BACKGROUND: Enhanced recovery after surgery (ERAS) programs have been proved effective for enhancing the clinical healing rate and reducing hospitalization cost in most countries of the world. It's a multi-model approach that designed to optimize perioperative pathway, attenuate the surgical st...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113004/ https://www.ncbi.nlm.nih.gov/pubmed/30142819 http://dx.doi.org/10.1097/MD.0000000000011957 |
_version_ | 1783350949886033920 |
---|---|
author | Jing, Xiaolin Zhang, Bingyuan Xing, Shichao Tian, Liqi Wang, Xiufang Zhou, Meng Li, Jiangfeng |
author_facet | Jing, Xiaolin Zhang, Bingyuan Xing, Shichao Tian, Liqi Wang, Xiufang Zhou, Meng Li, Jiangfeng |
author_sort | Jing, Xiaolin |
collection | PubMed |
description | BACKGROUND: Enhanced recovery after surgery (ERAS) programs have been proved effective for enhancing the clinical healing rate and reducing hospitalization cost in most countries of the world. It's a multi-model approach that designed to optimize perioperative pathway, attenuate the surgical stress response, and decrease postoperative complications. OBJECTIVE: The economic benefit from the application of ERAS to colorectal surgery has been demonstrated in China. However, such economic benefit of ERAS programs for hepatectomy hasn’t been clarified yet. This study was carried out to explore the clinical efficacy and cost effectiveness of ERAS in Chinese Han population after hepatectomy. METHODS: ERAS program was implemented in our department for hepatectomy in December 2016. In total, 79 consecutive patients after hepatectomy were chosen as ERAS group (ERAS protocol) in coming half year while 121 consecutive patients after hepatectomy were chosen as Pre-ERAS group (traditional protocol) in past half year. The operation time, intraoperative blood loss, length of hospital stay (LOS), complication, readmission, and hospitalization cost of 2 groups were compared. RESULTS: The LOS of ERAS group was 5.81 ± 1.79 days, significantly shorter than that of Pre-ERAS group (8.06 ± 3.40 d) (P = .000). The operation time was 168.03 ± 46.20 minutes for ERAS group and 175.41 ± 64.64 minutes for Pre-ERAS group respectively (P = .417). The intraoperative blood loss was 166.58 ± 194.13 mL (ERAS group) and 205.45 ± 279.63 mL (Pre-ERAS group) (P = .293). It should be noted that the hospitalization cost of ERAS group was 51556.18 ± 8926.05 Yuan (7835.05 ± 1355.45 US dollars), significantly less than that of Pre-ERAS group 60554.66 ± 15615.31 Yuan (9202.56 ± 2371.24 US dollars) (P = .000). The application of ERAS effectively saved 8998.48 Yuan (1367.51 US dollars) for each patient. CONCLUSIONS: ERAS implementation for hepatectomy surgery is safe and feasible for Chinese Han population. It eventually enhanced the clinical healing rate. The benefits from such programs include a reduction of the LOS, complication, and readmission rates. So each patient has access to better medical service. It effectively relieved the financial burden of patients. The benefits from such programs include a reduction of the hospitalization cost, especially in medication cost. So each patient can afford the diseases. |
format | Online Article Text |
id | pubmed-6113004 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-61130042018-09-07 Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population Jing, Xiaolin Zhang, Bingyuan Xing, Shichao Tian, Liqi Wang, Xiufang Zhou, Meng Li, Jiangfeng Medicine (Baltimore) Research Article BACKGROUND: Enhanced recovery after surgery (ERAS) programs have been proved effective for enhancing the clinical healing rate and reducing hospitalization cost in most countries of the world. It's a multi-model approach that designed to optimize perioperative pathway, attenuate the surgical stress response, and decrease postoperative complications. OBJECTIVE: The economic benefit from the application of ERAS to colorectal surgery has been demonstrated in China. However, such economic benefit of ERAS programs for hepatectomy hasn’t been clarified yet. This study was carried out to explore the clinical efficacy and cost effectiveness of ERAS in Chinese Han population after hepatectomy. METHODS: ERAS program was implemented in our department for hepatectomy in December 2016. In total, 79 consecutive patients after hepatectomy were chosen as ERAS group (ERAS protocol) in coming half year while 121 consecutive patients after hepatectomy were chosen as Pre-ERAS group (traditional protocol) in past half year. The operation time, intraoperative blood loss, length of hospital stay (LOS), complication, readmission, and hospitalization cost of 2 groups were compared. RESULTS: The LOS of ERAS group was 5.81 ± 1.79 days, significantly shorter than that of Pre-ERAS group (8.06 ± 3.40 d) (P = .000). The operation time was 168.03 ± 46.20 minutes for ERAS group and 175.41 ± 64.64 minutes for Pre-ERAS group respectively (P = .417). The intraoperative blood loss was 166.58 ± 194.13 mL (ERAS group) and 205.45 ± 279.63 mL (Pre-ERAS group) (P = .293). It should be noted that the hospitalization cost of ERAS group was 51556.18 ± 8926.05 Yuan (7835.05 ± 1355.45 US dollars), significantly less than that of Pre-ERAS group 60554.66 ± 15615.31 Yuan (9202.56 ± 2371.24 US dollars) (P = .000). The application of ERAS effectively saved 8998.48 Yuan (1367.51 US dollars) for each patient. CONCLUSIONS: ERAS implementation for hepatectomy surgery is safe and feasible for Chinese Han population. It eventually enhanced the clinical healing rate. The benefits from such programs include a reduction of the LOS, complication, and readmission rates. So each patient has access to better medical service. It effectively relieved the financial burden of patients. The benefits from such programs include a reduction of the hospitalization cost, especially in medication cost. So each patient can afford the diseases. Wolters Kluwer Health 2018-08-24 /pmc/articles/PMC6113004/ /pubmed/30142819 http://dx.doi.org/10.1097/MD.0000000000011957 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial License 4.0 (CCBY-NC), where it is permissible to download, share, remix, transform, and buildup the work provided it is properly cited. The work cannot be used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc/4.0 |
spellingShingle | Research Article Jing, Xiaolin Zhang, Bingyuan Xing, Shichao Tian, Liqi Wang, Xiufang Zhou, Meng Li, Jiangfeng Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population |
title | Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population |
title_full | Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population |
title_fullStr | Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population |
title_full_unstemmed | Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population |
title_short | Cost-benefit analysis of enhanced recovery after hepatectomy in Chinese Han population |
title_sort | cost-benefit analysis of enhanced recovery after hepatectomy in chinese han population |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6113004/ https://www.ncbi.nlm.nih.gov/pubmed/30142819 http://dx.doi.org/10.1097/MD.0000000000011957 |
work_keys_str_mv | AT jingxiaolin costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation AT zhangbingyuan costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation AT xingshichao costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation AT tianliqi costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation AT wangxiufang costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation AT zhoumeng costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation AT lijiangfeng costbenefitanalysisofenhancedrecoveryafterhepatectomyinchinesehanpopulation |